These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effect of varying chain length between P(1) and P(1') position of tripeptidomimics on activity of angiotensin-converting enzyme inhibitors. Chaudhary S; Vats ID; Chopra M; Biswas P; Pasha S Bioorg Med Chem Lett; 2009 Aug; 19(15):4364-6. PubMed ID: 19523823 [TBL] [Abstract][Full Text] [Related]
8. A comparison of the effects of angiotensin-converting enzyme inhibitors with bradykinin, angiotensin II and their specific antagonists on concanavalin A-induced proliferation of mouse T-lymphocytes. Yeung JH Methods Find Exp Clin Pharmacol; 1994 Apr; 16(3):163-72. PubMed ID: 8046949 [TBL] [Abstract][Full Text] [Related]
9. Modeling of the relationship between dipeptide structure and dipeptide stability, permeability, and ACE inhibitory activity. Foltz M; van Buren L; Klaffke W; Duchateau GS J Food Sci; 2009 Sep; 74(7):H243-51. PubMed ID: 19895477 [TBL] [Abstract][Full Text] [Related]
10. Antioxidant peptides with Angiotensin converting enzyme inhibitory activities and applications for Angiotensin converting enzyme purification. Hou WC; Chen HJ; Lin YH J Agric Food Chem; 2003 Mar; 51(6):1706-9. PubMed ID: 12617609 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin-I-converting enzyme inhibitory peptides: Chemical feature based pharmacophore generation. Wang Z; Zhang S; Jin H; Wang W; Huo J; Zhou L; Wang Y; Feng F; Zhang L Eur J Med Chem; 2011 Aug; 46(8):3428-33. PubMed ID: 21621881 [TBL] [Abstract][Full Text] [Related]
12. Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors. Coric P; Turcaud S; Meudal H; Roques BP; Fournie-Zaluski MC J Med Chem; 1996 Mar; 39(6):1210-9. PubMed ID: 8632427 [TBL] [Abstract][Full Text] [Related]
13. [Synthesis and biological activity of some Val(Ala)-Tyr and Val-Tyr-Tyr peptides]. Chen PL; Peng SX; Yang ZX Yao Xue Xue Bao; 1992; 27(12):895-902. PubMed ID: 1299138 [TBL] [Abstract][Full Text] [Related]
14. Performance of two commonly used angiotensin-converting enzyme inhibition assays using FA-PGG and HHL as substrates. Shalaby SM; Zakora M; Otte J J Dairy Res; 2006 May; 73(2):178-86. PubMed ID: 16476177 [TBL] [Abstract][Full Text] [Related]
15. The molecular mechanisms of interactions between bioactive peptides and angiotensin-converting enzyme. Pan D; Guo H; Zhao B; Cao J Bioorg Med Chem Lett; 2011 Jul; 21(13):3898-904. PubMed ID: 21640589 [TBL] [Abstract][Full Text] [Related]
16. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats. Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel keto-ACE analogues as domain-selective angiotensin I-converting enzyme inhibitors. Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED Bioorg Med Chem Lett; 2006 Sep; 16(17):4612-5. PubMed ID: 16784850 [TBL] [Abstract][Full Text] [Related]
19. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca. Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904 [TBL] [Abstract][Full Text] [Related]
20. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors. Georgiadis D; Beau F; Czarny B; Cotton J; Yiotakis A; Dive V Circ Res; 2003 Jul; 93(2):148-54. PubMed ID: 12805239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]